Clinical Trial Update: Study of the Safety and Immune Response of a Meningococcal Conjugate Vaccine Administered to Healthy Adolescents [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and immune response of a meningococcal conjugate vaccine in healthy adolescents. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• Meningococcal conjugate vaccine (MenACWY-CRM197) (Meningococcal conjugate vaccine)

Snippet

Sponsor: Novartis Vaccines | Conditions: Prevention of Meningococcal Disease | Phase 2 | Status: COMPLETED | Results posted: 2013-11-20